Illustration of semaglutide (blue, red and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3D structure across membrane). A G protein, part of the GLP-1 signalling cascade, is visible below the membrane (rounded multicoloured structure). Semaglutide is a GLP-1 receptor agonist, a type of drug that mimics the function of natural GLP-1 hormones. GLP-1 hormones are released in the gastrointestinal tract when we eat. They work by binding to GLP-1 receptors throughout the body and stimulating insulin secretion, inhibiting glucagon secretion, and slowing down gastric emptying. These effects all lower blood sugar levels, making semaglutide a treatment option for type 2 diabetes. Semaglutide is the active ingredient in Ozempic, a drug used to treat diabetes. | |
Lizenzart: | Lizenzpflichtig |
Credit: | Science Photo Library / Andrade, Ramon / 3dciencia |
Bildgröße: | 3520 px × 4977 px |
Modell-Rechte: | nicht erforderlich |
Eigentums-Rechte: | nicht erforderlich |
Restrictions: | - |